CINECA IRIS Institutional Research Information System

LAZZARATO, Loretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.281
EU - Europa 3.630
AS - Asia 2.154
SA - Sud America 149
AF - Africa 39
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.191
CN - Cina 959
IT - Italia 868
SG - Singapore 663
DE - Germania 654
IE - Irlanda 447
SE - Svezia 318
UA - Ucraina 232
FR - Francia 186
FI - Finlandia 182
AT - Austria 179
GB - Regno Unito 145
PL - Polonia 141
DK - Danimarca 132
BR - Brasile 126
KR - Corea 113
VN - Vietnam 77
CA - Canada 73
ID - Indonesia 73
IN - India 66
JP - Giappone 55
NL - Olanda 32
HK - Hong Kong 30
TR - Turchia 29
RU - Federazione Russa 24
BE - Belgio 18
CH - Svizzera 16
SN - Senegal 15
AU - Australia 14
MX - Messico 14
EG - Egitto 13
UZ - Uzbekistan 13
ES - Italia 12
TW - Taiwan 11
IR - Iran 8
JO - Giordania 8
EU - Europa 7
GR - Grecia 7
EC - Ecuador 6
IQ - Iraq 6
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
CZ - Repubblica Ceca 5
LT - Lituania 5
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
DZ - Algeria 3
HR - Croazia 3
PK - Pakistan 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AM - Armenia 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
MY - Malesia 2
NO - Norvegia 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
LU - Lussemburgo 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 12.281
Salva come PNG Salva come JPEG
Città #
Ann Arbor 698
Chandler 609
Fairfield 541
Dublin 442
Beijing 428
Ashburn 381
Santa Clara 377
Singapore 321
Woodbridge 268
Torino 252
Houston 244
Frankfurt am Main 215
Seattle 209
Wilmington 209
Cambridge 171
Vienna 167
Jacksonville 166
Pisa 146
Dearborn 136
Warsaw 132
Nyköping 126
Medford 108
Princeton 104
Villeurbanne 104
Columbus 92
Redwood City 77
Turin 72
Jakarta 71
Fremont 60
Shanghai 44
Dong Ket 43
Boardman 42
Boston 40
Milan 40
Helsinki 38
Nanjing 36
San Diego 34
Guangzhou 32
Munich 31
Hangzhou 29
Nuremberg 29
Toronto 29
Ottawa 26
Washington 23
Wuhan 22
New York 19
Brussels 18
Norwalk 18
Zhengzhou 18
Jinan 16
Silver Spring 15
Hefei 13
Naples 13
Phoenix 13
Pune 13
Siena 13
Changsha 12
Hong Kong 12
Shenyang 12
Falls Church 11
Guiyang 11
Rome 11
Verona 11
Bologna 10
Chengdu 10
Nürnberg 10
Tokyo 10
Council Bluffs 9
Leinì 9
London 9
Los Angeles 9
Paris 9
Cairo 8
Fuzhou 8
Kunming 8
Monmouth Junction 8
Taipei 8
Buffalo 7
Central District 7
Copenhagen 7
Dallas 7
Mumbai 7
Nanchang 7
São Paulo 7
Upper Marlboro 7
Xian 7
Amman 6
Changchun 6
Florence 6
Hebei 6
Lappeenranta 6
Seoul 6
Toledo 6
Ardabil 5
Catania 5
Chieri 5
Donetsk 5
Dresden 5
Falkenstein 5
Harbin 5
Totale 7.978
Salva come PNG Salva come JPEG
Nome #
Quinone based nitric oxide donating compounds 579
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 427
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells 314
Doxorubicin-antioxidant multitarget drugs 290
New furoxan derivatives for the treatment of ocular hypertension 288
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. 278
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 272
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 215
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 206
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis 204
New nitric oxide or hydrogen sulfide releasing aspirins 182
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 179
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis 179
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity 176
Combination of PDT and NOPDT with a tailored BODIPY derivative 174
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 173
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives 173
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 169
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents 169
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 166
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 163
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan 163
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 162
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 161
A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression 155
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 152
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 151
Synthesis and biological evaluation of the first example of NO-donor histone deacetylase inhibitor 148
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug 147
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors 146
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 143
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 141
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 140
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 140
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 139
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 138
Amphiphilic NO-Donor Antioxidants 138
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 137
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 135
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 134
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 134
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 129
Multitarget Drugs: Focus on the NO-donor hybrid drugs 129
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 125
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 124
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 121
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells 119
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 116
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 116
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 110
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 110
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 108
A new class of ibuprofen derivatives with reduced gastrotoxicity 107
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 107
DNA-targeted NO release photoregulated by green light 104
A novel hybrid aspirin-NO releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages 104
Mechanistic insights into cyclooxygenase irreversible inactivation byaspirin 103
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 94
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 90
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 90
Novel water soluble furoxan derivatives having antitumor activity 90
Can we exploit β-lactamases intrinsic dynamics for designing more effective inhibitors? 89
Amphiphile NO-donor antioxidants as polivalent drugs 87
A NEW CLASS OF BISPHOSPHONATES WITH NO-DONOR PROPERTIES 86
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs 85
Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin 84
GIFC-2018 - BOOK OF ABSTRACTS 77
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity 73
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models 72
nitric oxide furoxan derivative compounds endowed with antitumoral activity 71
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production 71
New class of NO-donor soluble aspirins 69
Structure-Antioxidant Activity Relationships in a Series of NO-Donor Phenols 67
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY 66
Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxide 66
Salicilic acid derivatives 65
BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES 64
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage 64
NO donor - melatonins: a new class of potential antiatherosclerosis agents 64
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib 63
A generator of peroxynitrite activatable with red light 62
Cryo-EM structures of staphylococcal IsdB bound to human hemoglobin reveal the process of heme extraction 56
NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY 56
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers 56
Synthesis of NO-Donor Bisphosphonates and Their in Vitro Action on Bone Resorption 55
New No-donor aspirin derivatives 54
New NO-donor Bisphosphonates 52
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 51
Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells 51
Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water soluble analogue of CHF 2363 50
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates 48
NO release regulated by doxorubicin as the green light-harvesting antenna 45
Michael addition of Grignard reagents to tetraethyl ethenylidenebisphosphonate 44
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 44
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma 39
NO-donor aspirin derivatives 39
Cryo-EM undiscloses structural and mechanistic details on iron hijacking by Staphylococcus aureus: An insight into the interaction of IsdB hemophore with human hemoglobin 37
Farmaci antiinfiammatori non steroidei 37
Multitarget antioxidant NO-donor organic nitrates: a novel ap-proach to overcome nitrates tolerance, an ex vivo study 37
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs 35
Totale 12.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.710
article - articoli 0
book - libri 0
conference - conferenze 4.454
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.164
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020693 0 0 0 0 0 0 0 0 223 207 150 113
2020/20211.314 120 99 88 82 118 82 82 92 174 133 72 172
2021/20221.634 134 91 113 149 91 57 116 107 76 91 349 260
2022/20231.822 173 173 54 160 148 433 229 93 170 71 75 43
2023/20241.046 111 140 64 66 88 173 42 57 21 75 83 126
2024/20251.927 68 191 162 228 511 183 112 128 344 0 0 0
Totale 12.626